Blood test doubles female heart attack diagnoses
A potentially groundbreaking heart attack test could save women’s lives, according to recent research. A study funded by…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jan 15
A potentially groundbreaking heart attack test could save women’s lives, according to recent research. A study funded by…
19 Nov 14
European regulators have given the green light to Gilead Sciences' hepatitis C combination treatment Harvoni.
31 Oct 14
Sales of drugs to treat age-related macular degeneration in the G7 pharmaceutical markets are set to grow 6%…
22 Oct 14
Octapharma, an independent manufacturer of human protein products, has added the PAS-X Track & Trace Serialisation Aggregation solution…
13 Aug 14
Japanese biotech company UNIGEN Inc. has taken Werum's PAS-X Manufacturing Execution System (MES) into operation within a record…
04 Jul 14
Swiss giant Roche is to pay $725 million to acquire breast cancer specialist Seragon Pharmaceuticals.
10 Jun 14
Whether you are a senior professional in a global pharmaceutical company or a smaller company looking to expand,…
30 May 14
Nexavar, the drug developed by Bayer and Amgen unit Onyx Pharmaceuticals to treat advanced kidney and liver cancers,…
25 Apr 14
Novartis has reached a definitive agreement with GlaxoSmithKline plc (GSK) to exchange certain assets, building global leadership in…
27 Mar 14
The European Commission has granted marketing authorisation for GlaxoSmithKline's (GSK) once-weekly diabetes treatment, Eperzan (albiglutide).